APA (7th ed.) Citation

AA, M., IG, A., MA, H., MA, A., AM, H., AA, E., . . . YO, M. (2026). Protopanaxadiol as a Dual-Action Therapeutic Agent: Enhancing Radiotherapy Efficacy and Mitigating DMBA-Induced Breast Cancer through Multi-Target Mechanisms. Current pharmaceutical design. https://doi.org/10.2174/0113816128425278251130191028

Chicago Style (17th ed.) Citation

AA, Mahmoud, et al. "Protopanaxadiol as a Dual-Action Therapeutic Agent: Enhancing Radiotherapy Efficacy and Mitigating DMBA-Induced Breast Cancer Through Multi-Target Mechanisms." Current Pharmaceutical Design 2026. https://doi.org/10.2174/0113816128425278251130191028.

MLA (9th ed.) Citation

AA, Mahmoud, et al. "Protopanaxadiol as a Dual-Action Therapeutic Agent: Enhancing Radiotherapy Efficacy and Mitigating DMBA-Induced Breast Cancer Through Multi-Target Mechanisms." Current Pharmaceutical Design, 2026, https://doi.org/10.2174/0113816128425278251130191028.